Xeris Biopharma Holdings, Inc. business relationships

Companies named in Xeris Biopharma Holdings, Inc.’s 10-K filed 2026-03-02, and public companies whose annual reports name Xeris Biopharma Holdings, Inc.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.

Open on the map Full AI visibility profile

AEO visibility: 4.2 / 10
AI naming: <1 / 100
Agent readiness: 0 / 100
AI adoption: 0 / 100

Layers: Peptides

Named in Xeris Biopharma Holdings, Inc.’s annual report 5

UNITEDHEALTH GROUP INC (UNH)Payor6.6
“For example, in February 2024, UnitedHealth Group announced that its Change Healthcare information technology systems that process payment claims for payors was being taken offline for an undefined period due to a cybersecurity incident, such incident could reduce demand for our products and harm ou...” SEC filing
Bachem (BCHMY)Supplier6.1
“We have entered into a non-exclusive supply agreement with Bachem.” SEC filing
REGIS CORP (RGS)Supplier6.1
“Similarly, for Recorlev, we rely on a number of single-source suppliers, such as Regis for API and Lonza for finished drug product.” SEC filing
Lonza Sales AGSupplier5.2
“Similarly, for Recorlev, we rely on a number of single-source suppliers, such as Regis for API and Lonza for finished drug product.” SEC filing
Cycle Pharmaceuticals LtdPartner4.7
“In May 2024, Torrent partnered with Cycle Pharmaceuticals Ltd ("Cycle Pharmaceuticals") to launch Ormalvi, a branded generic version of Keveyis.” SEC filing

Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.